Listed

Enveric Biosciences, Inc.: Form 10-Q/A for the period ended Jun 30, 2015

Filed with the SEC on Aug 18, 2015 and accepted by EDGAR at Aug 17, 2015, 17:49 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2015-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2015-04-01 to 2015-06-30$3.9mus-gaap:SalesRevenueNet
Cost of revenue3 months2015-04-01 to 2015-06-30$2.9mus-gaap:CostOfRevenue
Gross profit3 months2015-04-01 to 2015-06-30$982.7kus-gaap:GrossProfit
Operating income3 months2015-04-01 to 2015-06-30$188.0kus-gaap:OperatingIncomeLoss
Interest expense3 months2015-04-01 to 2015-06-30−$25.5kus-gaap:InterestExpense
Income tax3 months2015-04-01 to 2015-06-30$43.5kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2015-04-01 to 2015-06-30$111.0kus-gaap:NetIncomeLoss
Diluted EPS3 months2015-04-01 to 2015-06-30$0.01us-gaap:EarningsPerShareDiluted
Basic EPS3 months2015-04-01 to 2015-06-30$0.01us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2015-04-01 to 2015-06-3016,666,101 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2015-04-01 to 2015-06-30−$842.0kus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2015-06-30$4.4mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2015-06-30$9.3mus-gaap:AssetsCurrent
Total assetsAt period end2015-06-30$10.4mus-gaap:Assets
Current liabilitiesAt period end2015-06-30$9.3mus-gaap:LiabilitiesCurrent
Shareholders' equityAt period end2015-06-30$1.1mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001079974-15-000562. Last ingested by Listed: Nov 14, 2026, 20:02 ET. Listed shows no prices and gives no investment advice.